Literature DB >> 20071681

Inhibition of cytokine signaling in human retinal endothelial cells through downregulation of sphingomyelinases by docosahexaenoic acid.

Madalina Opreanu1, Todd A Lydic, Gavin E Reid, Kelly M McSorley, Walter J Esselman, Julia V Busik.   

Abstract

PURPOSE: The authors have previously demonstrated that DHA inhibits cytokine-induced inflammation in human retinal endothelial cells (HRECs), the resident vasculature affected by diabetic retinopathy. However, the anti-inflammatory mechanism of docosahexaenoic acid (DHA) is still not well understood. Sphingolipids represent a major component of membrane microdomains, and ceramide-enriched microdomains appear to be a prerequisite for inflammatory cytokine signaling. Acid sphingomyelinase (ASMase) and neutral sphingomyelinase (NSMase) are key regulatory enzymes of sphingolipid metabolism, promoting sphingomyelin hydrolysis to proinflammatory ceramide. The authors address the hypothesis that DHA inhibits cytokine-induced inflammatory signaling in HRECs by downregulating sphingomyelinases.
METHODS: ASMase and NSMase activity was determined by sphingomyelinase assay in primary cultures of HRECs. The expression of ASMase, NSMase, ICAM-1, and VCAM-1 was assessed by quantitative PCR and Western blot analysis. Gene silencing of ASMase and NSMase was obtained by siRNA treatment.
RESULTS: Inflammatory cytokines TNFalpha and IL-1beta induced cellular adhesion molecule (CAM) expression and rapid increase in ASMase and NSMase activity in HRECs. DHA decreased basal and cytokine-induced ASMase and NSMase expression and activity and the upregulation of CAM expression. Anti-inflammatory effects of DHA on cytokine-induced CAM expression were mimicked by inhibition/gene silencing of ASMase and NSMase. The sphingomyelinase pathway rather than ceramide de novo synthesis pathway was important for inflammatory signaling in HRECs.
CONCLUSIONS: This study provides a novel potential mechanism for the anti-inflammatory effect of DHA in HRECs. DHA downregulates the basal and cytokine-induced ASMase and NSMase expression and activity level in HRECs, and inhibition of sphingomyelinases in endothelial cells prevents cytokine-induced inflammatory response.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20071681      PMCID: PMC2891477          DOI: 10.1167/iovs.09-4731

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  66 in total

Review 1.  Compartmentalization of ceramide signaling: physical foundations and biological effects.

Authors:  R N Kolesnick; F M Goñi; A Alonso
Journal:  J Cell Physiol       Date:  2000-09       Impact factor: 6.384

2.  Flotillas of lipid rafts fore and aft.

Authors:  L M Pierini; F R Maxfield
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-14       Impact factor: 11.205

3.  Is diabetic retinopathy an inflammatory disease?

Authors:  A P Adamis
Journal:  Br J Ophthalmol       Date:  2002-04       Impact factor: 4.638

4.  Molecular mechanisms of ceramide-mediated CD95 clustering.

Authors:  H Grassmé; H Schwarz; E Gulbins
Journal:  Biochem Biophys Res Commun       Date:  2001-06-22       Impact factor: 3.575

5.  VIP21/caveolin is a cholesterol-binding protein.

Authors:  M Murata; J Peränen; R Schreiner; F Wieland; T V Kurzchalia; K Simons
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-24       Impact factor: 11.205

Review 6.  Ceramide/sphingosine/sphingosine 1-phosphate metabolism on the cell surface and in the extracellular space.

Authors:  Motohiro Tani; Makoto Ito; Yasuyuki Igarashi
Journal:  Cell Signal       Date:  2006-09-11       Impact factor: 4.315

7.  Leukocyte-mediated endothelial cell injury and death in the diabetic retina.

Authors:  A M Joussen; T Murata; A Tsujikawa; B Kirchhof; S E Bursell; A P Adamis
Journal:  Am J Pathol       Date:  2001-01       Impact factor: 4.307

Review 8.  n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases.

Authors:  Philip C Calder
Journal:  Am J Clin Nutr       Date:  2006-06       Impact factor: 7.045

9.  Ceramide enables fas to cap and kill.

Authors:  A Cremesti; F Paris; H Grassmé; N Holler; J Tschopp; Z Fuks; E Gulbins; R Kolesnick
Journal:  J Biol Chem       Date:  2001-04-03       Impact factor: 5.157

10.  Compartmentalized production of ceramide at the cell surface.

Authors:  P Liu; R G Anderson
Journal:  J Biol Chem       Date:  1995-11-10       Impact factor: 5.157

View more
  36 in total

Review 1.  Roles for dysfunctional sphingolipid metabolism in Alzheimer's disease neuropathogenesis.

Authors:  Norman J Haughey; Veera V R Bandaru; Mihyun Bae; Mark P Mattson
Journal:  Biochim Biophys Acta       Date:  2010-05-07

Review 2.  Inflammation in diabetic retinopathy.

Authors:  Johnny Tang; Timothy S Kern
Journal:  Prog Retin Eye Res       Date:  2011-05-25       Impact factor: 21.198

3.  Free insulin-like growth factor binding protein-3 (IGFBP-3) reduces retinal vascular permeability in association with a reduction of acid sphingomyelinase (ASMase).

Authors:  Jennifer L Kielczewski; Sergio Li Calzi; Lynn C Shaw; Jun Cai; Xiaoping Qi; Qing Ruan; Lin Wu; Li Liu; Ping Hu; Tailoi Chan-Ling; Robert N Mames; Sue Firth; Robert C Baxter; Patric Turowski; Julia V Busik; Michael E Boulton; Maria B Grant
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-10-21       Impact factor: 4.799

Review 4.  Beyond the cherry-red spot: Ocular manifestations of sphingolipid-mediated neurodegenerative and inflammatory disorders.

Authors:  Hui Chen; Annie Y Chan; Donald U Stone; Nawajes A Mandal
Journal:  Surv Ophthalmol       Date:  2013-09-05       Impact factor: 6.048

5.  ELOVL4-Mediated Production of Very Long-Chain Ceramides Stabilizes Tight Junctions and Prevents Diabetes-Induced Retinal Vascular Permeability.

Authors:  Nermin M Kady; Xuwen Liu; Todd A Lydic; Meesum H Syed; Svetlana Navitskaya; Qi Wang; Sandra S Hammer; Sandra O'Reilly; Chao Huang; Sergey S Seregin; Andrea Amalfitano; Vince A Chiodo; Sanford L Boye; William W Hauswirth; David A Antonetti; Julia V Busik
Journal:  Diabetes       Date:  2018-01-23       Impact factor: 9.461

6.  Effects of Docosahexaenoic Acid in Preventing Experimental Choroidal Neovascularization in Rodents.

Authors:  Sara Moghaddam-Taaheri; Monica Agarwal; Juan Amaral; Irina Fedorova; Elvira Agrón; Norman Salem; Emily Chew; S Patricia Becerra
Journal:  J Clin Exp Ophthalmol       Date:  2011-10-23

7.  The NF-kappaB signaling in cystic fibrosis lung disease: pathophysiology and therapeutic potential.

Authors:  Manish Bodas; Neeraj Vij
Journal:  Discov Med       Date:  2010-04       Impact factor: 2.970

8.  Docosahexanoic acid antagonizes TNF-α-induced necroptosis by attenuating oxidative stress, ceramide production, lysosomal dysfunction, and autophagic features.

Authors:  Fabio J Pacheco; Frankis G Almaguel; Whitney Evans; Leslimar Rios-Colon; Valery Filippov; Lai S Leoh; Elizabeth Rook-Arena; Melanie Mediavilla-Varela; Marino De Leon; Carlos A Casiano
Journal:  Inflamm Res       Date:  2014-08-06       Impact factor: 4.575

9.  Probiotics Supplemented with Omega-3 Fatty Acids are More Effective for Hepatic Steatosis Reduction in an Animal Model of Obesity.

Authors:  Nazarii Kobyliak; Tetyana Falalyeyeva; Petro Bodnar; Tetyana Beregova
Journal:  Probiotics Antimicrob Proteins       Date:  2017-06       Impact factor: 4.609

Review 10.  Omega-3 fatty acid supplementation and cardiovascular disease.

Authors:  Donald B Jump; Christopher M Depner; Sasmita Tripathy
Journal:  J Lipid Res       Date:  2012-08-17       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.